Skip to main content
    D

    Dianthus Therapeutics Inc. (DNTH)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $89.55
    -2.26 (-2.46%)

    Market Cap: $5.17B

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Dianthus Therapeutics Inc. (DNTH) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Dianthus Therapeutics (DNTH) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Dianthus Therapeutics reported EPS of -$0.81, above the -$0.95 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    56%(19/34)
    Avg Surprise
    -18.61%
    Streak
    3 Q

    Upcoming Estimates

    Reports Mar 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.98
    Range-$1.06 - -$0.88
    17 analysts
    Revenue Consensus
    $445.82K
    RangeN/A
    17 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$1.03
    Range-$1.12 - -$0.93
    7 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$1.10+5.9%
    60d ago-$1.10+6.2%
    30d ago-$1.09+5.2%
    7d ago-$1.09+5.2%
    Current-$1.03
    Revenue Consensus
    $460.28K
    RangeN/A
    8 analysts

    Next Report

    DNTH has an expected report date of Mar 8, 2027.

    Earnings History

    Of the 34 quarters below that had an estimate, DNTH beat 19 and missed 15. The widest gap in the table came in the quarter ended Sep 30, 2023, when EPS landed 575.00% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.81-$0.95-$1.13 - -$0.39+14.74%BeatN/A102 up, 1 downNov 4, 2026$1.21M
    Jun 30, 2026-$0.90-$0.93-$1.23 - -$0.72+3.23%BeatN/A81 up, 0 downAug 4, 2026$761000
    Mar 31, 2026-$0.85-$1.10-$1.56 - -$0.63+22.73%BeatN/A7N/AMay 5, 2026N/A
    Dec 31, 2025-$1.43-$1.03-$2.01 - -$0.72-38.65%MissN/A71 up, 0 downMar 9, 2026$873000
    Sep 30, 2025-$0.97-$0.86-$1.03 - -$0.76-12.79%MissN/A70 up, 1 downNov 5, 2025N/A
    Jun 30, 2025-$0.88-$0.86-$0.93 - -$0.81-2.33%MissN/A30 up, 1 downAug 7, 2025N/A
    Mar 31, 2025-$0.82-$0.71-$0.71 - -$0.71-15.49%MissN/A10 up, 0 downMay 12, 2025$1.16M
    Dec 31, 2024-$0.81-$0.76-$0.76 - -$0.76-6.58%MissN/A10 up, 0 downMar 11, 2025$1.33M
    Sep 30, 2024-$0.74-$0.60-$0.73 - -$0.50-23.33%MissN/A90 up, 0 downNov 7, 2024$2.17M
    Jun 30, 2024-$0.51-$0.55-$0.85 - -$0.28+7.27%BeatN/A90 up, 0 downAug 8, 2024$1.86M
    Mar 31, 2024-$0.54-$0.44N/A-22.73%MissN/A30 up, 0 downMay 9, 2024$874000
    Dec 31, 2023-$0.71-$1.01-$1.05 - -$0.64+29.70%BeatN/A30 up, 0 downMar 21, 2024$457000
    Sep 30, 2023-$3.78-$0.56N/A-575.00%MissN/A10 up, 0 downNov 9, 2023$924000
    Jun 30, 2023-$0.87-$3.04N/A+71.50%BeatN/AN/AN/AAug 3, 2023$969000
    Mar 31, 2023-$0.47-$0.40N/A-17.50%MissN/AN/AN/AMay 11, 2023$476000
    Dec 31, 2022-$0.30-$0.28N/A-8.62%MissN/AN/AN/AMar 29, 2023$5.24M
    Sep 30, 2022-$0.27-$0.29N/A+6.90%BeatN/AN/AN/ANov 3, 2022$1.17M
    Jun 30, 2022-$0.29-$0.34N/A+14.71%BeatN/AN/AN/AAug 4, 2022N/A
    Mar 31, 2022-$0.39-$0.32N/A-22.60%MissN/AN/AN/AMay 16, 2022N/A
    Dec 31, 2021-$0.33-$0.32N/A-4.13%MissN/AN/AN/AMar 8, 2022N/A
    Sep 30, 2021-$0.30-$0.33N/A+8.68%BeatN/AN/AN/ANov 4, 2021N/A
    Jun 30, 2021-$0.32-$0.37N/A+14.09%BeatN/AN/AN/AAug 5, 2021N/A
    Mar 31, 2021-$0.36-$0.39N/A+7.22%BeatN/AN/AN/AMay 6, 2021N/A
    Dec 31, 2020-$0.38-$0.39N/A+2.06%BeatN/AN/AN/AMar 3, 2021N/A
    Sep 30, 2020-$0.37-$0.43N/A+13.95%BeatN/AN/AN/ANov 5, 2020N/A
    Jun 30, 2020-$0.48-$0.54N/A+11.11%BeatN/AN/AN/AAug 6, 2020N/A
    Mar 31, 2020-$0.51-$0.60N/A+15.00%BeatN/AN/AN/AMay 7, 2020N/A
    Dec 31, 2019-$0.59-$0.58N/A-1.72%MissN/AN/AN/AMar 3, 2020N/A
    Sep 30, 2019-$0.54-$0.53N/A-1.89%MissN/AN/AN/ANov 13, 2019N/A
    Jun 30, 2019-$0.48-$0.49N/A+2.04%BeatN/AN/AN/AAug 8, 2019N/A
    Mar 31, 2019-$0.44-$0.55N/A+20.00%BeatN/AN/AN/AMay 9, 2019N/A
    Dec 31, 2018-$0.50-$0.53N/A+5.66%BeatN/AN/AN/AMar 19, 2019N/A
    Sep 30, 2018-$0.49-$0.67N/A+26.87%BeatN/AN/AN/ANov 8, 2018N/A
    Jun 30, 2018-$3.13-$1.13N/A-176.99%MissN/AN/AN/AAug 9, 2018N/A
    Mar 31, 2018-$4.45N/AN/AN/AN/AN/AN/AN/AMay 30, 2018N/A
    Dec 31, 2017-$1.03N/AN/AN/AN/AN/AN/AN/AMar 30, 2018N/A
    Mar 31, 2017-$0.15N/AN/AN/AN/AN/AN/AN/AJun 29, 2017N/A
    Last 37 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.10, after -$2.60 the year before. It was -$1.18 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.10N/A
    Dec 31, 2024-$2.60N/A
    Dec 31, 2023-$5.83N/A
    Dec 31, 2022-$1.25N/A
    Dec 31, 2021-$1.31N/A
    Dec 31, 2020-$1.74N/A
    Dec 31, 2019-$2.05N/A
    Dec 31, 2018-$8.57N/A
    Dec 31, 2017-$1.18N/A

    Frequently Asked Questions About DNTH

    When is Dianthus Therapeutics's next earnings date?

    Dianthus Therapeutics's next earnings report is expected for Mar 8, 2027.

    Did DNTH beat earnings estimates last quarter?

    Yes. Dianthus Therapeutics reported EPS of -$0.81 for the quarter ended Sep 30, 2026, above the -$0.95 estimate, a 14.74% surprise.

    What EPS do analysts expect from DNTH next quarter?

    The consensus EPS estimate for Dianthus Therapeutics for the quarter ending Dec 31, 2026 is -$0.98 from 17 analysts, with estimates from -$1.06 to -$0.88.

    How often does DNTH beat earnings estimates?

    Dianthus Therapeutics beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -4.39%.